Par Drugs and Chemicals Limited (PAR.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 967.24M |
| Enterprise Value | 548.81M |
| P/E Ratio | 9.03 |
| PEG Ratio | -4.67 |
| Price/Sales Ratio | 1.14 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | 0.74 |
| Enterprise/EBITDA | 3.93 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 1.04B |
| Revenue/Share | 83.79 |
| Gross Profit | 504.71M |
| EBITDA | 171.32M |
| Net Income | 131.09M |
| Diluted EPS | 10.65 |
Balance Sheet
| Total Cash | 418.43M |
| Total Cash/Share | 33.82 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.68 |
| Book Value Per Share | 90.52 |
Price History
| 52-Week Change | 0.24 |
| 52-Week High | 122.43 |
| 52-Week Low | 78.05 |
| Moving Average 50 Days | 90.61 |
| Moving Average 200 Days | 95.18 |
Statistics
| Average Volume | 10,754 |
| Shares Outstanding | 12.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | April 27, 2021 |
AD
